Cargando…
Iron(II) Complexes Supported by Sulfonamido Tripodal Ligands: Endogenous versus Exogenous Substrate Oxidation
[Image: see text] High-valent iron species are known to act as powerful oxidants in both natural and synthetic systems. While biological enzymes have evolved to prevent self-oxidation by these highly reactive species, development of organic ligand frameworks that are capable of supporting a high-val...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American
Chemical Society
2014
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4203402/ https://www.ncbi.nlm.nih.gov/pubmed/25264932 http://dx.doi.org/10.1021/ic501531g |
_version_ | 1782340397045907456 |
---|---|
author | Cook, Sarah A. Ziller, Joseph W. Borovik, A. S. |
author_facet | Cook, Sarah A. Ziller, Joseph W. Borovik, A. S. |
author_sort | Cook, Sarah A. |
collection | PubMed |
description | [Image: see text] High-valent iron species are known to act as powerful oxidants in both natural and synthetic systems. While biological enzymes have evolved to prevent self-oxidation by these highly reactive species, development of organic ligand frameworks that are capable of supporting a high-valent iron center remains a challenge in synthetic chemistry. We describe here the reactivity of an Fe(II) complex that is supported by a tripodal sulfonamide ligand with both dioxygen and an oxygen-atom transfer reagent, 4-methylmorpholine-N-oxide (NMO). An Fe(III)–hydroxide complex is obtained from reaction with dioxygen, while NMO gives an Fe(III)–alkoxide product resulting from activation of a C–H bond of the ligand. Inclusion of Ca(2+) ions in the reaction with NMO prevented this ligand activation and resulted in isolation of an Fe(III)–hydroxide complex in which the Ca(2+) ion is coordinated to the tripodal sulfonamide ligand and the hydroxo ligand. Modification of the ligand allowed the Fe(III)–hydroxide complex to be isolated from NMO in the absence of Ca(2+) ions, and a C–H bond of an external substrate could be activated during the reaction. This study highlights the importance of robust ligand design in the development of synthetic catalysts that utilize a high-valent iron center. |
format | Online Article Text |
id | pubmed-4203402 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | American
Chemical Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-42034022015-09-29 Iron(II) Complexes Supported by Sulfonamido Tripodal Ligands: Endogenous versus Exogenous Substrate Oxidation Cook, Sarah A. Ziller, Joseph W. Borovik, A. S. Inorg Chem [Image: see text] High-valent iron species are known to act as powerful oxidants in both natural and synthetic systems. While biological enzymes have evolved to prevent self-oxidation by these highly reactive species, development of organic ligand frameworks that are capable of supporting a high-valent iron center remains a challenge in synthetic chemistry. We describe here the reactivity of an Fe(II) complex that is supported by a tripodal sulfonamide ligand with both dioxygen and an oxygen-atom transfer reagent, 4-methylmorpholine-N-oxide (NMO). An Fe(III)–hydroxide complex is obtained from reaction with dioxygen, while NMO gives an Fe(III)–alkoxide product resulting from activation of a C–H bond of the ligand. Inclusion of Ca(2+) ions in the reaction with NMO prevented this ligand activation and resulted in isolation of an Fe(III)–hydroxide complex in which the Ca(2+) ion is coordinated to the tripodal sulfonamide ligand and the hydroxo ligand. Modification of the ligand allowed the Fe(III)–hydroxide complex to be isolated from NMO in the absence of Ca(2+) ions, and a C–H bond of an external substrate could be activated during the reaction. This study highlights the importance of robust ligand design in the development of synthetic catalysts that utilize a high-valent iron center. American Chemical Society 2014-09-29 2014-10-20 /pmc/articles/PMC4203402/ /pubmed/25264932 http://dx.doi.org/10.1021/ic501531g Text en Copyright © 2014 American Chemical Society Terms of Use (http://pubs.acs.org/page/policy/authorchoice_termsofuse.html) |
spellingShingle | Cook, Sarah A. Ziller, Joseph W. Borovik, A. S. Iron(II) Complexes Supported by Sulfonamido Tripodal Ligands: Endogenous versus Exogenous Substrate Oxidation |
title | Iron(II)
Complexes Supported by Sulfonamido Tripodal
Ligands: Endogenous versus Exogenous Substrate Oxidation |
title_full | Iron(II)
Complexes Supported by Sulfonamido Tripodal
Ligands: Endogenous versus Exogenous Substrate Oxidation |
title_fullStr | Iron(II)
Complexes Supported by Sulfonamido Tripodal
Ligands: Endogenous versus Exogenous Substrate Oxidation |
title_full_unstemmed | Iron(II)
Complexes Supported by Sulfonamido Tripodal
Ligands: Endogenous versus Exogenous Substrate Oxidation |
title_short | Iron(II)
Complexes Supported by Sulfonamido Tripodal
Ligands: Endogenous versus Exogenous Substrate Oxidation |
title_sort | iron(ii)
complexes supported by sulfonamido tripodal
ligands: endogenous versus exogenous substrate oxidation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4203402/ https://www.ncbi.nlm.nih.gov/pubmed/25264932 http://dx.doi.org/10.1021/ic501531g |
work_keys_str_mv | AT cooksaraha ironiicomplexessupportedbysulfonamidotripodalligandsendogenousversusexogenoussubstrateoxidation AT zillerjosephw ironiicomplexessupportedbysulfonamidotripodalligandsendogenousversusexogenoussubstrateoxidation AT borovikas ironiicomplexessupportedbysulfonamidotripodalligandsendogenousversusexogenoussubstrateoxidation |